This cross-sectional observational study evaluated the availability and switching patterns of branded generics of Vildagliptin, an antidiabetic medication, in a real-world setting. Data from 967 prescriptions obtained from various pharmacies over a 3-month period post-patent expiration were analyzed. The study revealed a diverse range of branded generics, highlighting challenges in consistent availability. Switching patterns were observed, with a significant proportion of patients deviating from the initially prescribed branded generic. These findings emphasize the need for strategies to improve availability and promote appropriate use of branded generics, enhancing cost-effective diabetes management and patient care. Further research is warranted to investigate factors influencing brand switching behaviors and their impact on patient outcomes. This study provides valuable insights for optimizing the prescribing and availability of branded generics, ultimately enhancing the quality of care for patients requiring Vildagliptin treatment.

Medically qualified clinical pharmacologists specialise in drugs and their usage. Thus, a clinical pharmacologist should be involved in patient education, drug development, access and utilisation research, policy and procedure development, and safer medicine use. India has 5.2 million medication errors yearly, which are just a fraction of healthcare system incidents. Clinical pharmacological reconciliation, review, and feedback (CPRRF) is essential to reduce medication-related tragedies. Clinical pharmacologists can employ CPRRF principles to improve patient safety and efficacy.To improve patient safety, the World Health Organisation wants to integrate Clinical Pharmacology into the health care system. However, this is taking time. Policymakers should design and execute novel strategies to speed up this process.